What really matters in hearing aids #shorts

Description

A randomized clinical trial assessed hearing aid service models and technology levels among patients with mild to moderate hearing loss. Audiologist-fitted prescription hearing aids resulted in better patient outcomes than both over-the-counter (OTC) and hybrid OTC+ service models, although all models yielded generally positive results. No significant differences were observed between high-end and low-end hearing aid technologies for patient-reported outcomes. JAMA Otolaryngology—Head & Neck Surgery Editor in Chief Jay F. Piccirillo, MD, selected this study as one of the best clinical trials published in JAMA Otolaryngology in 2025, highlighting its rigor, timeliness, and actionability following the federal availability of OTC hearing aids in 2022. These findings inform clinical decision-making and illustrate how rigorous research can shape clinical practice. How can clinicians and researchers stay up to date on the most clinically relevant trials? JAMA+ Trials highlights the implications and innovations of clinical trial research from across the JAMA Network to advance evidence-based medicine and public health. Follow JAMA+ Trials to get curated access to the best of the JAMA Network’s trial research, commentaries, and educational resources. 📖 Read the full trial: https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2025.1008?guestAccessKey=b8735475-7f40-49cd-acf9-e89d5ba43e65 #clinicaltrials #hearingaids #otc